The Prezalumab Biosimilar Anti-B7-H2 Antibody is a cutting-edge tool for researchers studying immune regulation and inflammatory diseases. This monoclonal antibody, developed as a biosimilar version of the original drug, targets the B7-H2 protein - a key player in immune responses and inflammatory pathways.By binding specifically to B7-H2, this antibody allows for precise detection and analysis in various experimental settings, such as flow cytometry and immunohistochemistry. Its high specificity and sensitivity make it a valuable tool for investigating the role of B7-H2 in diseases like cancer, autoimmune disorders, and chronic inflammation.
The Prezalumab Biosimilar Anti-B7-H2 Antibody is a reliable reagent for researchers looking to unravel the complex mechanisms of immune regulation and develop targeted therapies for a range of inflammatory conditions. Its validated performance in various research applications makes it an essential tool for advancing our understanding of immune response modulation and disease pathology.
Product Name:
Prezalumab (Anti-B7-H2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0075
Target:
B7-H2
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AMG557, AMG-557, MEDI-5872
Description:
Anti-B7-H2(prezalumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
